Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seasons | 4 | 2022 | 1526 | 0.770 |
Why?
|
| Oxygen | 4 | 2021 | 4273 | 0.710 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2021 | 389 | 0.680 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 1882 | 0.620 |
Why?
|
| Antipyretics | 1 | 2017 | 23 | 0.590 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 57 | 0.540 |
Why?
|
| Hypercapnia | 1 | 2017 | 260 | 0.490 |
Why?
|
| Rhinitis | 1 | 2022 | 751 | 0.470 |
Why?
|
| Menstrual Cycle | 1 | 2018 | 545 | 0.460 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2023 | 1891 | 0.450 |
Why?
|
| Bronchial Provocation Tests | 1 | 2013 | 216 | 0.430 |
Why?
|
| Methacholine Chloride | 1 | 2013 | 220 | 0.430 |
Why?
|
| Asthma, Exercise-Induced | 1 | 2012 | 23 | 0.410 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2012 | 34 | 0.400 |
Why?
|
| Rhenium | 1 | 2011 | 14 | 0.400 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2012 | 79 | 0.400 |
Why?
|
| Pyruvates | 1 | 2012 | 83 | 0.390 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2013 | 272 | 0.380 |
Why?
|
| Altitude Sickness | 1 | 2012 | 92 | 0.370 |
Why?
|
| Overweight | 1 | 2022 | 2445 | 0.370 |
Why?
|
| Electroporation | 1 | 2012 | 236 | 0.360 |
Why?
|
| Fever | 2 | 2017 | 1620 | 0.350 |
Why?
|
| Respiration | 1 | 2017 | 1667 | 0.340 |
Why?
|
| Sweat | 1 | 2009 | 57 | 0.330 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2011 | 677 | 0.290 |
Why?
|
| Tibia | 1 | 2013 | 1075 | 0.280 |
Why?
|
| Oximetry | 3 | 2021 | 462 | 0.270 |
Why?
|
| Ultrasonic Therapy | 1 | 2008 | 217 | 0.270 |
Why?
|
| Asthma | 3 | 2014 | 6280 | 0.260 |
Why?
|
| Hemoglobins | 1 | 2012 | 1532 | 0.260 |
Why?
|
| Exercise Test | 2 | 2012 | 2186 | 0.240 |
Why?
|
| Specimen Handling | 1 | 2009 | 708 | 0.240 |
Why?
|
| Doxorubicin | 1 | 2011 | 2229 | 0.240 |
Why?
|
| Hepatocytes | 1 | 2012 | 1245 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 4069 | 0.230 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2019 | 2336 | 0.230 |
Why?
|
| Boronic Acids | 1 | 2008 | 915 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1890 | 0.220 |
Why?
|
| Hypertension | 1 | 2023 | 8615 | 0.210 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3434 | 0.210 |
Why?
|
| Pyrazines | 1 | 2008 | 1206 | 0.200 |
Why?
|
| Cystic Fibrosis | 2 | 2009 | 1285 | 0.200 |
Why?
|
| Adrenal Cortex | 1 | 2002 | 134 | 0.200 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2734 | 0.190 |
Why?
|
| Budesonide | 1 | 2002 | 162 | 0.190 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4365 | 0.180 |
Why?
|
| Laser Therapy | 2 | 2020 | 1105 | 0.180 |
Why?
|
| Israel | 3 | 2018 | 726 | 0.180 |
Why?
|
| Pulmonary Emphysema | 2 | 2020 | 690 | 0.180 |
Why?
|
| Bone Density | 1 | 2013 | 3559 | 0.170 |
Why?
|
| Lactate Dehydrogenases | 1 | 2019 | 26 | 0.170 |
Why?
|
| Pituitary-Adrenal System | 1 | 2002 | 557 | 0.160 |
Why?
|
| Parturition | 1 | 2022 | 453 | 0.150 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 705 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 2020 | 244 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2002 | 577 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 2923 | 0.140 |
Why?
|
| Body Surface Area | 1 | 2018 | 206 | 0.140 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 529 | 0.140 |
Why?
|
| Oxyhemoglobins | 1 | 2017 | 213 | 0.140 |
Why?
|
| Child, Preschool | 10 | 2022 | 42650 | 0.140 |
Why?
|
| Altitude | 2 | 2021 | 164 | 0.130 |
Why?
|
| Adenoids | 1 | 2016 | 35 | 0.130 |
Why?
|
| Ablation Techniques | 1 | 2019 | 255 | 0.130 |
Why?
|
| Liver | 1 | 2012 | 7574 | 0.130 |
Why?
|
| Bronchi | 1 | 2020 | 849 | 0.130 |
Why?
|
| Adolescent | 11 | 2022 | 89184 | 0.130 |
Why?
|
| Palatine Tonsil | 1 | 2016 | 193 | 0.130 |
Why?
|
| Administration, Inhalation | 2 | 2013 | 1169 | 0.120 |
Why?
|
| Endosonography | 1 | 1999 | 622 | 0.120 |
Why?
|
| Pneumonia | 2 | 2022 | 2163 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 2429 | 0.120 |
Why?
|
| Child | 10 | 2022 | 80891 | 0.120 |
Why?
|
| Male | 22 | 2023 | 364902 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2002 | 1841 | 0.120 |
Why?
|
| Ventilators, Mechanical | 1 | 2017 | 292 | 0.120 |
Why?
|
| Trachea | 1 | 2020 | 1095 | 0.110 |
Why?
|
| Infant | 9 | 2022 | 36510 | 0.110 |
Why?
|
| Progesterone | 1 | 2018 | 751 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2020 | 6001 | 0.110 |
Why?
|
| Sex Factors | 2 | 2018 | 10654 | 0.110 |
Why?
|
| Pancreas | 1 | 1999 | 1702 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18362 | 0.100 |
Why?
|
| Female | 19 | 2023 | 397089 | 0.100 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 417 | 0.100 |
Why?
|
| Thyroid Nodule | 1 | 2019 | 767 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1006 | 0.090 |
Why?
|
| Risk | 1 | 2023 | 9636 | 0.090 |
Why?
|
| Hypoventilation | 1 | 2011 | 44 | 0.090 |
Why?
|
| Humans | 28 | 2023 | 768393 | 0.090 |
Why?
|
| Empyema | 1 | 2010 | 41 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2660 | 0.090 |
Why?
|
| Pleurisy | 1 | 2010 | 54 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2019 | 2886 | 0.090 |
Why?
|
| Sleep Apnea, Central | 1 | 2011 | 88 | 0.090 |
Why?
|
| Prevalence | 3 | 2022 | 15872 | 0.090 |
Why?
|
| Iontophoresis | 1 | 2009 | 75 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2011 | 110 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 14737 | 0.080 |
Why?
|
| Reference Values | 2 | 2012 | 4941 | 0.080 |
Why?
|
| Young Adult | 5 | 2017 | 60049 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 1248 | 0.080 |
Why?
|
| Polysomnography | 1 | 2016 | 1865 | 0.080 |
Why?
|
| Adenoma | 1 | 2020 | 2163 | 0.080 |
Why?
|
| Adult | 10 | 2022 | 223640 | 0.080 |
Why?
|
| Infant, Newborn | 5 | 2020 | 26411 | 0.080 |
Why?
|
| Electric Conductivity | 1 | 2009 | 408 | 0.080 |
Why?
|
| Sweating | 1 | 2009 | 155 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2010 | 239 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 1014 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2017 | 6241 | 0.080 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 1820 | 0.080 |
Why?
|
| Pneumonia, Bacterial | 1 | 2010 | 319 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 1998 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2010 | 344 | 0.070 |
Why?
|
| Chlorides | 1 | 2009 | 663 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2010 | 393 | 0.070 |
Why?
|
| Risk Factors | 3 | 2023 | 74962 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4250 | 0.070 |
Why?
|
| Heart Rate | 1 | 2018 | 4218 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 619 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 1999 | 2776 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2008 | 519 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13697 | 0.060 |
Why?
|
| Cysts | 1 | 2010 | 685 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2017 | 12166 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2341 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3471 | 0.060 |
Why?
|
| Animals | 8 | 2019 | 169337 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 1696 | 0.050 |
Why?
|
| Colonic Polyps | 1 | 2008 | 557 | 0.050 |
Why?
|
| Inhalation Spacers | 1 | 2002 | 4 | 0.050 |
Why?
|
| Depression, Chemical | 1 | 2002 | 186 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 848 | 0.050 |
Why?
|
| Absorption | 1 | 2002 | 243 | 0.050 |
Why?
|
| Powders | 1 | 2002 | 79 | 0.050 |
Why?
|
| Tetralogy of Fallot | 1 | 2008 | 628 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2360 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2020 | 65379 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 1359 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 998 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 13042 | 0.050 |
Why?
|
| Biological Availability | 1 | 2002 | 392 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2010 | 1241 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 30200 | 0.050 |
Why?
|
| Colon | 1 | 2008 | 1805 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2010 | 1925 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2022 | 334 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 8562 | 0.040 |
Why?
|
| Aerosols | 1 | 2002 | 637 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2018 | 13052 | 0.040 |
Why?
|
| Pancreatic Function Tests | 1 | 1999 | 69 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12092 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 205 | 0.040 |
Why?
|
| Pneumococcal Vaccines | 1 | 2022 | 414 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18471 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2002 | 2106 | 0.030 |
Why?
|
| Pancreatitis | 1 | 2003 | 1087 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2020 | 350 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2019 | 640 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59686 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 26375 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3411 | 0.030 |
Why?
|
| Respiration, Artificial | 3 | 2011 | 2721 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 4076 | 0.030 |
Why?
|
| Swine | 2 | 2008 | 5994 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 21544 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20224 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2016 | 562 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2020 | 913 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2022 | 81801 | 0.030 |
Why?
|
| Aged | 4 | 2020 | 171562 | 0.030 |
Why?
|
| Rabbits | 1 | 2019 | 4781 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 223491 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9516 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1539 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21162 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 36849 | 0.020 |
Why?
|
| Neck | 1 | 2016 | 736 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3617 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 793 | 0.020 |
Why?
|
| High-Frequency Ventilation | 1 | 2010 | 90 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2010 | 153 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39407 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 2972 | 0.020 |
Why?
|
| Hospitalization | 2 | 2022 | 10844 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 54920 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 2925 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2820 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1525 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 82017 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5336 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 30228 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 2392 | 0.020 |
Why?
|
| Drainage | 1 | 2010 | 1184 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 15939 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 899 | 0.010 |
Why?
|
| Lung | 1 | 2002 | 10089 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 1320 | 0.010 |
Why?
|
| Amylases | 1 | 2003 | 171 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20765 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 1945 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2010 | 7463 | 0.010 |
Why?
|
| Lipase | 1 | 2003 | 321 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2528 | 0.010 |
Why?
|
| Bacteria | 1 | 2010 | 2221 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2008 | 2894 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2003 | 1417 | 0.010 |
Why?
|
| Gestational Age | 1 | 2003 | 3615 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13646 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7242 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 7955 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 8506 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 24318 | 0.000 |
Why?
|
| Time Factors | 1 | 2010 | 40272 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14154 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41795 | 0.000 |
Why?
|
Concepts
(218)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_